DFE Pharma

Diwali is a time for new beginnings. A time to remember we can make it through the dark times.

We join our colleagues and customers to celebrate this festival of lights. May this Diwali bring you renewed joy, wellbeing and prosperity!

Interested in our expanded production capacity for MCC? Meet us at Supply Side West!

Join us in Las Vegas, NV and learn more about Nutroféli ™, our portfolio of natural excipients for the nutraceutical industry, and key product offerings:

✔️Nutracel™ MCC 101 & 102 - with expanded production capacity
✔️Pharmacel® sMCC 90 – to enhance the flowability of direct compression tablet formulations
✔️Primojel® sodium starch glycolate – mouth-feel enhancing, non-GMO superdisintegrant
✔️Primellose® croscarmellose sodium – for rapid tablet disintegration

Visit our booth #4072 for a chance to win prizes, including Apple AirPods Pro2.

We're ready to support you in your inhalation product development. Together with our partners Harro Hofliger and Sterling, we're proud to announce that INTO has reached an agreement with Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases

Under this collaboration, we will support the development of TRB-5, TRB-6 and TRB-7, inhaled medicines for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD).

As INTO, a unique consortium of leading partners, we will provide Transpire Bio with the knowledge and support for their formulations.

To learn more about INTO, get in touch with our team.

CPHI South-East Asia is the only end-to-end event in Asia, and we will be there to share our expertise and support you with your formulation challenges.

Rohit Seksaria, Sushil Gupte, and Victor Luong will be happy to meet you in Thailand. Visit us at Maxway's booth

Do you need support with your inhalation formulation? Come meet us at MVIC ! Xander van Leeuwen and Pauline Janssen will be happy to share their expertise.

More than 100 attendees joined Pauline Janssen's presentation about Product Development Strategies for high doses and biologics for Inhalation. If you're interested in learning more about this topic, contact us: https://bit.ly/3II9FWV

As the respiratory market keeps growing and evolving, there is an increased need for knowledge about Dry Powder Inhalation (DPI) and R&D services.

We would like to thank all participants who joined us for our seminar on Dry Powder Inhalation in Sao Paulo, Brazil. The panelists provided an in-depth perspective of the latest trends in DPI, regulatory environment, new technologies and solutions, followed by great questions from the audience.

Special thanks to our sponsor Harro Hofliger and experts Mohit Mehta, Gustavo Lima Santos, Pauline Janssen, Valker Feitosa, Alison Madrid, Claudemar Papini and Marco Laackman for sharing their expertise.

Ensuring the distribution of critical ingredients to market is key for us as a manufacturer of high-quality excipients for biopharmaceutical applications.

We're proud to announce a new U.S. distribution agreement with Spectrum Chemical, a leading provider of specialty, fine chemicals. The company will market and distribute our BioHale® Sucrose and BioHale® Trehalose Dihydrate excipients, which are essential ingredients used in the manufacture of biologics, including several COVID-19 vaccines. Because stability matters.

Spectrum Chemical's expertise in biologics makes for an ideal partnership. We are looking forward to growing this relationship.

Read more: https://bwnews.pr/3e1JrDO

What is your key formulation challenge? We're ready to support you, meet us at CPHI: bit.ly/DFEPharmaCPHI2022

Our team of experts will be in Frankfurt from November 1-3. Visit us in hall 8.0, booth 80D80 (gold area).

With a broad excipient portfolio covering oral solid dose, Biopharma and inhalation, and more than 100 years of experience, we work with our global customers to provide specific products and solutions for every formulation challenge, while offering top quality and guaranteed security of supply.

According to the World Heart Federation, 18.6 million people die every year from cardiovascular disease with heart attacks and stroke accounting for 85% of these deaths.

At DFE Pharma, ❤️ healthcare access to life-saving medicines is one of our top priorities. As a global leader in the development of high quality excipients, we provide a comprehensive excipient portfolio across the various dosage forms to support our customers and their patients with their drug formulation needs.